Intravesical oxybutynin in the pediatric neurogenic bladder

Nat Rev Urol. 2009 Dec;6(12):671-4. doi: 10.1038/nrurol.2009.214. Epub 2009 Nov 10.

Abstract

Pediatric neuropathic bladder dysfunction can cause irreversible renal damage and urinary incontinence. Etiologically, it is usually the consequence of a congenital neural tube defect. The majority of affected children can be successfully managed with the standard medical treatment of clean intermittent catheterization and anticholinergic (typically oxybutynin) medication. A subset of patients experience severe side effects or insufficient suppression of detrusor overactivity on oral oxybutynin. Intravesical instillations offer an effective alternative; this Review considers their indications, administration, safety and efficacy.

Publication types

  • Review

MeSH terms

  • Administration, Intravesical
  • Child
  • Humans
  • Mandelic Acids / administration & dosage*
  • Muscarinic Antagonists / administration & dosage*
  • Urinary Bladder, Neurogenic / drug therapy*

Substances

  • Mandelic Acids
  • Muscarinic Antagonists
  • oxybutynin